Go Lower and PCOS

Citation

(2011), "Go Lower and PCOS", Nutrition & Food Science, Vol. 41 No. 2. https://doi.org/10.1108/nfs.2011.01741bab.033

Go Lower and PCOS

Article Type: Food facts From: Nutrition & Food Science, Volume 41, Issue 2

Polycystic Ovary Syndrome (PCOS) is associated with many medical abnormalities such as central obesity, high cholesterol, type 2 diabetes and insulin resistance. Abdominal fat is strongly associated with insulin and insulin resistance. However, it has been shown that obese patients with PCOS have higher insulin and more severe insulin resistance than obese control groups, meaning that although obesity does bring about high risks of insulin resistance through central obesity, having PCOS can enhance this risk further. The metabolic consequences of having insulin resistance are also increased in PCOS, independent of obesity, including an adverse cardiovascular profile (increased risk of coronary heart disease, high cholesterol, etc.), impaired glucose tolerance and prevalence of the metabolic syndrome. In order to treat PCOS, following a regime that lowers insulin levels and insulin resistance, which subsequently results in weight loss, would prove effective. Studies have shown that a low-carbohydrate Ketogenic diet (LCKD) can lead to weight loss and improvements in insulin resistance. It has been further shown that adherence to a low-carbohydrate diet led to improvements in body weight, hormone levels, fasting serum insulin and symptoms in women with diagnosed PCOS.

Go Lower is an effective therapy for people with PCOS to follow as it offers reductions in insulin levels and improves insulin resistance meaning that all other risks are reduced. People on the go lower diet with PCOS have also noticed vast drops in their weight which will also bring improvements to the condition. If you would like any further information on how an LCKD helps with the treatment of PCOS and other co-morbidities, please visit: nutrition@golower.co.uk